Trading Options with an Edge
Select Page

PCRX

Search by
TICKER SYMBOL

Pacira BioSciences Inc

Sector:
Industry:

57.43

1.15

(2.043%)

Volume:

460,777

52 week range:

45.05 - 82.16

Market Cap:

2.609B

Company Description:

Pacira BioSciences, Inc.is the industry leader in its commitment to non-opioid pain management and regenerative health solutions to improve patients' journeys along the neural pain pathway. The company's long-acting local analgesic, EXPAREL ® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In April 2019, Pacira acquired the iovera° system, a handheld cryoanalgesia device used to deliver precise, controlled doses of cold temperature only to targeted nerves.